Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
Clinical trial NCT03126630 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03126630
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2023-05-04
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.